These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 11698287

  • 1. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N, Shima H, Nakamura K, Kikuchi K.
    Blood; 2001 Nov 15; 98(10):3030-4. PubMed ID: 11698287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S, Jaruga B, Kim WH, Heller T, Liang TJ, Gao B.
    Biochem J; 2004 Apr 01; 379(Pt 1):199-208. PubMed ID: 14690454
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 8. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Müller-Newen G.
    J Immunol; 2003 Mar 15; 170(6):3263-72. PubMed ID: 12626585
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
    Park ES, Kim H, Suh JM, Park SJ, You SH, Chung HK, Lee KW, Kwon OY, Cho BY, Kim YK, Ro HK, Chung J, Shong M.
    Mol Endocrinol; 2000 May 15; 14(5):662-70. PubMed ID: 10809230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
    Chen CW, Chang YH, Tsi CJ, Lin WW.
    J Immunol; 2003 Jul 15; 171(2):979-88. PubMed ID: 12847270
    [Abstract] [Full Text] [Related]

  • 14. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T.
    Nature; 1997 Jun 26; 387(6636):924-9. PubMed ID: 9202127
    [Abstract] [Full Text] [Related]

  • 15. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.
    You M, Yu DH, Feng GS.
    Mol Cell Biol; 1999 Mar 26; 19(3):2416-24. PubMed ID: 10022928
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.
    Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, Marchi M, Suzuki R, Suzuki A, Yoshimura A.
    Blood; 1999 Oct 15; 94(8):2880-9. PubMed ID: 10515892
    [Abstract] [Full Text] [Related]

  • 17. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D, Kerr IM, Heinrich PC.
    Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [Abstract] [Full Text] [Related]

  • 18. A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.
    Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A.
    Blood; 1998 Sep 01; 92(5):1668-76. PubMed ID: 9716595
    [Abstract] [Full Text] [Related]

  • 19. Initiation and maintenance of CNTF-Jak/STAT signaling in neurons is blocked by protein tyrosine phosphatase inhibitors.
    Jiao J, Kaur N, Lu B, Reeves SA, Halvorsen SW.
    Brain Res Mol Brain Res; 2003 Aug 19; 116(1-2):135-46. PubMed ID: 12941469
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.
    Sengupta TK, Schmitt EM, Ivashkiv LB.
    Proc Natl Acad Sci U S A; 1996 Sep 03; 93(18):9499-504. PubMed ID: 8790359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.